GSK Investigational Site

San Mateo, California 94403

0 studies enrolling now · 3 studies all time

What they study most

Asthma, Diabetes Mellitus, Type 2, Hepatitis C, Chronic

Studies at this site

• A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With Asthma — Completed
• Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive — Completed
• Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease — Completed